Xconomy Health Tech
Pharma and software firms are actively embracing AI and machine learning, but governments may need to lead the way in accessing relevant data, says Molecular Health.
Molecular Health, a software firm focused on transforming big data into analysis and prediction tools for healthcare companies, believes biotech is in the early days of using artificial intelligence (AI) and machine learning in drug discovery and development.
It is not the technology available holding the industry back, but the managing and the monitoring of the data involved, according to Molecular Health CEO Friedrich von Bohlen.
“In certain parts of the process we can [embrace... Read more »
When Mark Bakken formed the healthcare technology investment firm HealthX Ventures nearly five years ago, he says hospitals, insurers, and other potential buyers of digital health products were less open to conversations with the kinds of early-stage healthtech startups Bakken’s firm wanted to back.
At the time, healthcare organizations’ top priority was installing electronic medical records systems and getting the most out of the technology, Bakken says. That’s still important to them today, but “that’s been kind of stabilized,” he says.
“They’re realizing [electronic health records software] doesn’t solve all their problems, so they’re looking to augment that” with additional... Read more »
Nuance Communications’ plan to lighten the clerical burden on physicians is coming into focus, and it involves an assist from tech giant Microsoft.
Nuance (NASDAQ: NUAN), the 27-year-old speech recognition technology pioneer, in February revealed it’s developing a device that would sit in exam rooms and listen to conversations between doctors and patients. The system’s artificial intelligence-based software works in the background to capture the exchange, parse clinically significant information, and automatically save it in the correct spots in patients’ electronic medical records. Doctors could also use voice commands to quickly retrieve information, such as a person’s treatment history. The... Read more »
Five years ago, the big tech incubator Y Combinator started to welcome life sciences companies into its sizable startup classes, which had previously nurtured entrepreneurs in information technology almost exclusively.
That opening to biotech startups in 2014 was controversial at the time. Some observers simply wondered what kind of guidance a deeply tech-focused accelerator could offer to biology lab scientists messing with live cells and tissues, and facing lengthy development times for new medical treatments.
Others worried about a new startup model that was emerging for young biologists who were frustrated with career barriers at universities and constraints on government grant... Read more »
Digital health is having a moment, thanks to a convergence of increasingly sophisticated computing technologies, a more favorable regulatory environment, and growing buy-in from hospitals, insurers, and patients. But plenty of challenges and questions remain.
Join Xconomy on Oct. 22 for an elite conference that will help industry stakeholders better understand the most promising opportunities and potential pitfalls for their businesses and organizations.
Our second annual X·CON conference, “Digital Health Gets Real,” features many of the leading companies and experts shaping the future of the intersection of healthcare and technology: John Halamka of Beth Israel Lahey Health; Rosalind Picard of... Read more »